Are you Watching AXXE?

Recommended Stock Newsletters
#1. PennyStockWarfare
#2. Nova Stocks
#3. Penny Stock Finder

StockMister Newsletter

Trouble viewing this email Read it online Today`s pick is: **AXXE**

Do you have AXXE on your Radar for Today The Action could pick up so watch it closely!!

This weekend interruption comes with a possibly promising result.

There’s plenty of time before the markets open and we can’t help but let you all know that a familiar stock that may be ready to make another move in the direction that benefits our followers.

AXXE (Axxess Pharma, Inc.) AXXE is a specialty Health Care Products Company dedicated to improving health and quality of life by offering select medicines, nutritional supplements and over the counter remedies all across the Americas.

On this past Thursday, AXXE, along with TapouT Fitness, announced an exclusive alliance to supply gyms with TapouT products.

Their management teams are now preparing for a “Nationwide” rollout of the TapouT line into over 25 TapouT fitness gyms within a year.

TapouT is a lifestyle brand that has been at the forefront of Mixed Martial Arts since its inception in 1997. The label is rapidly growing into other sports and categories, offering merchandise for men, women and kids. TapouT has endorsed high-profile professional athletes who compete in sports such as basketball, football, baseball, stock car racing, and most famously, MMA. TapouT is sold in sporting goods stores, specialty retailers and online. For updates and more information, please visit Follow TapouT on Facebook, Twitter and YouTube.

Now back to the story of their recent press release.

TORONTO, ON–(Marketwired – Dec 10, 2014) – Axxess Pharma, Inc. (OTCPK: AXXE), a specialty pharmaceutical and nutritional supplements company, through its wholly owned subsidiary, AllStar Health Brands Inc., is pleased to announce they now have an exclusive alliance to supply two TapouT Fitness gyms with TapouT products in the greater Cincinnati and greater Atlanta areas.

AllStar Health Brands has already received two initial Purchase Orders (POs) from the TapouT gyms. The purchase orders are for the TapouT Muscle Recovery, Topical Pain, TapouT Turbo Blend Protein Powder and TapouT Muscle Growth and Muscle Recovery Supplements.

TapouT Fitness is planning to open over 25 new locations in the US in 2015, including international expansion in the same year, growing to over 100 locations within three years.

Based on market research, TapouT Fitness expects 1,000-15,000 members visiting per week, depending on size of gym and location.

Ben Crosbie, President of TapouT Fitness, stated, “We are very pleased to partner with Axxess and AllStar as we strongly believe in providing our clientele with well-researched, all-natural products to help with their overall health improvement strategies.” Mr. Crosbie further stated, “TapouT Fitness is not an MMA Gym or fight club; we focus 100% on enhancing fitness. We provide group classes and one-on-one training for any man, woman, or family to deliver total body transformation and avoid stagnation or boredom. TapouT Fitness has researched the top fitness techniques in the country to offer the world`s “Best and the Best” fitness platforms, equipment, and training — all in one location. Our personal trainers will be educated on the best use of proteins and supplements and how to transmit this information to our clientele. Our research shows most people who go to gyms have little or no knowledge of the correct use of protein and other supplements.” Dr. Bagi, President of Axxess Pharma, stated, “We are very proud to be aligned with TapouT Fitness as they grow nationally and globally. We see a perfect synergy between our high demand TapouT product line and their TapouT Fitness gyms. TapouT Fitness will be educating the public in the proper use of our products which are aimed at maximizing their workout performance and improving their health. We will be offering seminars, instruction brochures, and other support to help educate the public on the best use of protein and supplements at the TapouT Fitness gyms.” Dr. Bagi further stated, “More and more people are taking steps to improve their health, maximize their workouts, and use of protein and supplements.” BUSINESS SUMMARY (AXXE – Axxess Pharma, Inc.)

Axxess Pharma, Inc. is a Nevada Corporation operating through its wholly owned Canadian subsidiary: Axxess Pharma Canada Inc., headquartered in Toronto. Axxess is a specialty Health Care Products Company dedicated to improving health and quality of life by offering select medicines, nutritional supplements and over the counter remedies all across the Americas. Axxess`s goal is to bring additional products to the market and provide new, innovative options for better health spanning areas such as high cholesterol, blood pressure, acute pain — to optimal health management through improved nutritional supplements. To learn more about our new products TapouT Extreme Muscle Growth and TapouT Muscle Recovery, visit: and

Axxess Pharma: a focused healthcare company dedicated to providing a wide range of products to improve the lives of patients and consumers worldwide.

They believe action defines leadership.

Their products are targeted to improve health-related conditions including several forms of iron deficiency, bone loss, rheumatoid arthritis, migraine headaches, urinary tract infections, infant cradle cap, joint pain and much more. Axxess Pharma intends to market these products with affordable pricing and widespread availability. Our company will continue to tap the well of innovation to develop ever-more effective and affordable treatment options for the patients we serve, and also foster innovation in education, leadership and advocacy.

Personal passion concerning the well-being of chronic illness sufferers is a major driving force and at the heart of our company. Affordable, proven, prescription and non-prescription products are a critical component to their company Business Plan. They balance environmental impact, social contribution, and financial results. Axxess Pharma is publicly traded on the US stock exchange under the ticker symbol: AXXE.

MARKET OUTLOOK The over-the-counter (OTC) pharmaceutical market includes non- prescription medicines that are sold directly to consumers through pharmacies, drugstores, convenience stores and grocery stores. Most countries follow the “two-class system” for the classification of medicines as prescription (Rx) or non-prescription (OTC). The OTC pharmaceutical market may be segmented into multiple categories such as analgesics, cold, cough and allergy, digestive remedies, traditional medicines, and vitamins and minerals.

A new report by visiongain predicts that the world market for over-the-counter (OTC) medicines will reach $80.7 billion for 2014. That revenue forecast appears in World OTC Pharmaceutical Market 2012-2022 INVESTOR HIGHLIGHTS AXXE has seen spurts of positive action throughout the last few months; a combination of all this new informative material could send this thing up.

AXXE has released multiple important press releases that warrants investor’s attention, (in my unlicensed, amateur opinion).

AXXE appears to have the right combination for success in one the largest global industries.

AXXE is a small-cap company with the potential to show big swings.

AXXE has an experienced team that is looking out for the companies/shareholders best interests.

Take your time and do your own analyzing and research now. This could be an opportunity for something special.

By now you all know the drill but sometimes some important details get forgotten, so remember, never risk more than you could afford to lose and always book a profit when you can.

Please sign up for my FREE Text Message list. Almost always e-mails take long to be received and when I send out my 9:30-9:35AM EST play’s they start flying super fast! So in order for everyone to get these play’s at EXACTLY the time I release them, you need to be a text message subscriber! It’s really easy to become a member: Just grab your cellphone and Text the word “Stocks” to “95577″ (standard text messaging rates may apply).

Also always remember that every single alert I send is very volatile and risky. Any one of them could turn into a big loser. In my personal opinion, no matter how much potential any company has, 99% of the time all that matters is HOW THE STOCK TRADES. If a stock doesn’t trade well, nothing else matters. Don’t believe the hype. Be sure to use a tight stop, book profits quickly on these volatile trades, never let any one trade move too far against you, watch out for gaps, make sure the stock is trading in a healthy way before you enter, and monitor it closely to make sure momentum is positive. It’s always safest to book profits quickly, even on alerts with long-term potential. (Amateur biased unlicensed opinions)

I would like to also explain how my Newsletter Makes MONEY!!

I DON’T FRONTLOAD, BUY, RECEIVE any SHARES of a Company I Profile!! I NEVER OWN ANY POSITION IN A COMPANY I ALERT/PROFILE!! It would be UNFAIR, WRONG and ILLEGAL for me to have a position in ANY Company I ever Profile on my Newsletter! I am what is known as a STOCK PROMOTER!!

I just wanted to address this issue for some people who might think I trade the companies I profile on my Newsletter or I own a position before or during the time I profile them!!! The honest truth is I DO NOT!!….. I do get CASH compensation to profile companies most of the times I talk about them in my Newsletter, this is HOW I MAKE MONEY and pretty much how 99% of ALL the other Newsletters out there make money…… Most of you have signed up to my Newsletter because of an advertisement you saw, well it costs money to run those advertisements…. I ALWAYS Disclose how much and who paid me in my Disclaimer at the end of each e-mail!!!

Here is some information directly from the SEC Website:

Tips for Checking Out Newsletters

“Find out whether the newsletter received payment to “tout” or recommend the stock and, if so, what it received and from whom.

Because the U.S. Constitution’s First Amendment protects freedom of speech, the SEC cannot simply prohibit newsletters from recommending or touting particular stocks. But when newsletters receive payment for touting, the securities laws require them to disclose specifically who paid them, the amount, and the type of payment (cash, stock, or some other thing of value).

Read carefully what the newsletter says about payments it receives.

Be suspicious of newsletters that do not specifically disclose these items: who paid them, the amount, and the type of payment. The following examples raise red flags because they do not contain specific information:

“From time to time, XYZ Newsletter may receive compensation from companies we write about.”

“From time to time, XYZ Newsletter or its officers, directors, or staff may hold stock in some of the companies we write about.”

“XYZ Newsletter receives fees from the companies we write about in our newsletter.”

Think twice about newsletters that bury their disclosures or put them in tiny, hard-to-read typeface. Legitimate online newsletters that have been paid to tout stocks will clearly and specifically tell investors who paid them, the amount, and the type of payment. Look for their disclosure statements in articles about particular companies or in a list or chart on their websites.”

I hope this answers a lot of your questions and also gives you a better perspective to my play’s the Next Time you see one!! Don’t forget to tell everyone you know about and help my Newsletter Grow!!

Remember to trade smart, research your options, and use due diligence!


The Team

Disclaimer and Release of Liability We are engaged in the business of advertising and promoting companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.’s sponsored advertisements do not purport to provide an analysis of any company’s financial position, operations or prospects and this is not to be construed as a recommendation by or an offer or solicitation to buy or sell any security. Neither the owner of nor any of its members, officers, directors, contractors or employees is licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases. It is possible that a viewer’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed in a release or on our website unless you can afford to lose your entire investment. Also, investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. To review our complete disclaimer and additional information, please visit makes no recommendation that the securities of the companies profiled or discussed in our releases or on our website should be purchased, sold or held by investors. is owned and operated by Micro-Cap Consultants LLC. Micro-Cap Consultants LLC has been compensated up to Fifteen-Thousand Dollars Cash via Bank Wire Transfer by a third party (Freedom Ventures) for a 1 Day Marketing Program regarding AXXE. Any compensation received by Micro-Cap Consultants LLC constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. A third party of Micro-Cap Consultants LLC may have shares and may liquidate, which may negatively affect the stock price. Micro-Cap Consultants LLC affiliates may at any time have a position in the securities mentioned herein and may increase or decrease such positions without notice which will negatively affect the market.

Some of the content in this release contains forward – looking information within the meaning of Section 27 A of the Securities Act of 1 9 9 3 and Section 21 E of the Securities Exchange Act of 1 9 3 4 including statements regarding expected continual growth of the profiled company and the value of its securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 it is hereby noted that statements contained herein that look forward in time which include everything other than historical information, involve risk and uncertainties that may affect a company`s actual results of operation. A company`s actual performance could greatly differ from those described in any forward – looking statements or announcements mentioned in this release. Factors that should be considered that could cause actual results to differ include: the size and growth of the market for the company`s products; the company`s ability to fund its capital requirements in the near term and in the long term; pricing pressures; unforeseen and/or unexpected circumstances in happenings; etc. and the risk factors and other factors set forth in the company’s filings with the Securities and Exchange Commission. However, a company’s past performance does not guarantee future results.

Generally, the information regarding a company profiled is provided from public sources which we believe to be reliable but is not guaranteed by us as being accurate. Further specific financial information, filings and disclosures as well as general investor information about the profiled company, advice to investors and other investor resources are available at the Securities and Exchange Commission (“SEC”) website and the Financial Industry Regulatory Authority (“FINRA”) website at Any investment should be made only after consulting with a qualified investment advisor and reviewing the publicly available financial statement and other information about the company profiled and verifying that the investment is appropriate and suitable. makes no representations, warranties or guarantees as to the accuracy or completeness of the information provided or discussed. Viewers should not rely solely on the information obtained in this release or on our website. Viewers should use the information provided by us regarding the profiled companies as a starting point for additional independent research on the companies profiled or discussed in order to allow the viewer to form his or her own opinion regarding investing in the securities of such companies. Factual statements, or the similar, made by the profiled companies are made as of the date stated and are subject to change without notice and has no obligation to update any of the information provided., its owners, officers, directors, contractors and employees are not responsible for errors and omissions.

From time to time certain content in our releases or website is written and published by our employees or third parties. In addition to information about our profiled companies, from time to time, our releases and website will contain the symbols of companies and/or news feeds about companies that are not being profiled by us but are merely illustrative of certain activity in the micro cap or pennystock market that we are highlighting. Viewers are advised that all analysis reports and news feeds are issued solely for informational purposes. Any opinions expressed are subject to change without notice. It is also possible that one or more of the companies discussed or profiled in our release or on our website may not have approved certain or any statements within the website. encourages viewers to supplement the information obtained from this release and our website with independent research and other professional advice. The content in this release is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data.

This release may provide hyperlinks to third party websites or access to third party content., its owners, officers, directors, contractors and employees are not responsible for errors and omissions nor does control, endorse, or guarantee any content found in such sites. By accessing, viewing, or using the website or communications originating from this release, you agree that, its owners, officers, directors, contractors and employees, are not responsible for any content, associated links, resources, or services associated with a third party website. You further agree that, its owners, officers, directors, contractors and employees shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only. uses third parties to disseminate information to subscribers. Although we take precautions to prevent others from obtaining our subscriber list, there is a risk that our subscriber list, through no wrong doing on our part, could end up in the hands of an unauthorized party and that subscribers will receive communications from unauthorized third parties.

You agree to hold, its operators, owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur arising out of the use of our website or the information in our press releases, profiles and opinions. You agree that use of our website is at your sole risk. disclaims all warranties of any kind, express or implied.

We encourage viewers to invest carefully and read the investor issuer information available at the web sites of the SEC. The SEC has launched an investor-focused website to help you invest wisely and avoid fraud at and filings made by public companies can be viewed at and/or then FINRA In addition, FINRA has published information at its website on how to invest carefully at
You are subscribed to this mailing list as . Please click here to modify your message preferences or

This entry was posted in StockMister and tagged . Bookmark the permalink.

Comments are closed.